In conclusion, curcumol targets NQO2 and engages a ROS‐driven ER stress‐CHOP‐DR5‐dependent pathway to overcome TRAIL resistance of NSCLC (Figure 8H). This evidence concerns the gene DDIT3 and non-small cell lung carcinoma.